Free shipping on all orders over $ 500

Go 6983

Cat. No. M2019

All AbMole products are for research use only, cannot be used for human consumption.

Go 6983 Structure
Synonym:

Goe 6983; Gö 6983

Size Price Availability Quantity
1mg USD 34 In stock
5mg USD 78 In stock
10mg USD 128 In stock
25mg USD 256 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Go 6983 is a protein kinase C (PKC) inhibitor with IC50 values of 7 nM, 7 nM, 6 nM, 10 nM and 60 nM for PKCα, PKCβ, PKCγ, PKCδ and PKCζ respectively. Go 6983 inhibited intracellular Ca(2+) accumulation, suggesting a mechanism for its vasodilator properties. In vitro, Go 6983 significantly inhibited antigen-induced superoxide release from leukocytes of patients previously sensitized to tree pollen. Go 6983 (100 nM) significantly reduced PMN adherence to the endothelium and infiltration into the myocardium compared with I/R + PMN hearts (P < 0.01), and significantly inhibited superoxide release from PMNs by 90 +/- 2% (P < 0.01). Go 6983 attenuated post-I/R cardiac contractile dysfunction, which may be related in part to decreased superoxide production in the presence of PMNs.

Customer Product Validations & Biological Datas
Source Immunobiology (2012). Figure 4. Go 6983
Method Flow cytometry
Cell Lines Tca8113 cells
Concentrations 5 μM
Incubation Time 24 h
Results As shown in Fig. 4, after PKD2 was inhibited by Gö6983, IFN-γ could not induce the surface expression of PD-L1 on Tca8113.
Chemical Information
Molecular Weight 442.51
Formula C26H26N4O3
CAS Number 133053-19-7
Solubility (25°C) DMSO ≥ 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Young LH, et al. Cardiovasc Drug Rev. Gö 6983: a fast acting protein kinase C inhibitor that attenuates myocardial ischemia/reperfusion injury.

[2] Chen J, et al. Mol Pharmacol. Protein kinase C-independent effects of protein kinase D3 in glucose transport in L6 myotubes.

[3] Peterman EE, et al. J Cardiovasc Pharmacol. Gö 6983 exerts cardioprotective effects in myocardial ischemia/reperfusion.

Related PKC Products
Enzastaurin

Enzastaurin inhibits PKCβ, PKCα, PKCγ and PKCε with IC50's of 0.006, 0.039, 0.083 and 0.110 µM, respectively.

Staurosporine

Staurosporine (AM-2282) is a potent ATP-competitive kinase inhibitor with IC50 of 0.7, 7, 8.5, 6, 20 nM for PKC, PKA,PKG, p60v-src tyrosine protein kinase, CaM kinase II, respectively.

Zoledronic acid

Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects.

Dequalinium Chloride

Dequalinium Chloride is a PKC inhibitor with IC50 of 7-18 μM, and also a selective blocker of apamin-sensitive K+ channels with IC50 of 1.1 μM.

K252a

K252a is an inhibitor of the BDNF receptor TrkB. K-252a inhibits protein kinase with IC50 values of 470 nM, 140 nM, 270 nM, and 1.7 nM for PKC, PKA, Ca2+/calmodulin-dependent kinase type II, and phosphorylase kinase, respectively. K-252a is a potent inhibitor (IC50 of 3 nM) of the tyrosine protein kinase (TRK) activity of the NGF receptor gp140trk, the product of the trk protooncogene.

  Catalog
Abmole Inhibitor Catalog




Keywords: Go 6983, Goe 6983; Gö 6983 supplier, PKC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.